布地奈德胶囊是化痰还是治咳嗽

Budesonide, chemical name: 16a, 17a-22R, S-propylmethylenedioxy-pregnant-1,4-diene-11b, 21-dihydroxy-3,20-dione (16a(R), 17-(Butylidenebis(oxy))-11b, 21- dihydroxypregna-1, 4-diene-3, 20-dione), budesonide was first developed and marketed by AstraZeneca Pharmaceutical Company in 1981. Budesonide is a halogen-free topical glucocorticoid. Budesonide has a strong The mechanism of local anti-inflammatory effect may be: enhancing the stability of mast cells and lysosomal membranes, reducing degranulation and the release of lysosomal enzymes; anti-immune effect, inhibiting inflammation caused by immune response, etc.; for patients with airway hyperresponsiveness, this product can significantly reduce the airway response to histamine and methacholine. Does budesonide capsule reduce phlegm or treat cough?

It is understood that budesonide capsules do not reduce phlegm or cure coughs. Budesonide capsules are currently one of the most commonly used drugs to treat asthma in various countries around the world.

Usage and dosage of budesonide capsules: Adults generally use 1-2 mg of budesonide once, twice a day; children use 0.5-1 mg once, twice a day. The maintenance dose should be individualized, that is, the lowest dose to maintain no symptoms. It is recommended that adults take 0.5-1 mg twice a day and children 0.25-0.5 mg twice a day. 

Patients using budesonide should avoid concurrent treatment with ketoconazole or other CYP3A4 inhibitors, and avoid concomitant ingestion of grapefruit juice; budesonide 3 mg capsules contain lactose and sucrose. Patients with rare hereditary problems of galactose or fructose intolerance, glucose-galactose malabsorption, sucrase isomaltase deficiency, Lapp lactase deficiency, or congenital lactase deficiency should not take this medicine.